Narus Financial Partners, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1698091 SALT LAKE CITY, UT

Position in BMY

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$382,366

-$15,558 QoQ

Shares Held

6,636

+1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#1,698

of 2,506 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Narus Financial Partners, LLC holds $2,295,659 across 6 Drug Manufacturers - General names. BMY ranks #3 (16.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,388	$600,916
2	LLY	ELI LILLY & Co	437	$524,150
3	BMY	Bristol Myers Squibb Co This page	6,636	$382,366
4	NVS	Novartis AG	1,889	$296,044
5	JNJ	Johnson & Johnson	1,024	$260,065
6	AMGN	Amgen Inc	641	$232,118

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$382,366	6,636	+1.1%	Shares	Sole	2026-07-31
2026-03-31	$397,924	6,561	-0.8%	Shares	Sole	2026-04-21
2025-12-31	$356,813	6,615	+49.7%	Shares	Sole	2026-02-09
2023-09-30	$256,420	4,418	-2.6%	Shares	Sole	2023-10-30
2023-06-30	$290,013	4,535	-0.5%	Shares	Sole	2023-08-30
2023-03-31	$315,914	4,558	+2.3%	Shares	Sole	2023-06-27
2022-12-31	$320,609	4,456	0.0%	Shares	Sole	2023-10-12
2022-09-30	$316,777	4,456	-1.1%	Shares	Sole	2023-10-12
2022-06-30	$346,962	4,506	+36.1%	Shares	Sole	2023-10-12
2022-03-31	$241,729	3,310	-3.5%	Shares	Sole	2023-09-12
2021-03-31	$216,599	3,431	—	Shares	Sole	2024-03-07
No filing history on record for this holder in this stock.